UHRF1 overexpression [28, 29] has been reported to correlate with unfavorable prognosis in many cancers, including breast [37], lung [38, 39], colorectal [30, 40], prostate [41], bladder [42, 43], and gastric cancer [44]. Here, UHRF1 is linked to cancer.